InnoCore Pharmaceuticals

InnoCore specializes in the formulation, process development, and manufacturing of long acting and minimally invasive injectable drug delivery products. InnoCore offers a unique and highly tunable polymer platform to control the delivery drug compounds, including small molecules (e.g. peptides and low solubles) and biologics (e.g. proteins and antibodies). Our proprietary polymer platform features a variety of benefits to your APIs such as: - solving toxicity challenges - maintaining/increasing stability and structural integrity of sensitive compounds (e.g. by applying low temperature process conditions during manufacturing) - sustained release of of drug molecules from days up to at least 6 months -...

Solid implants,injectable microspheres,in-situ forming implants,synbiosys polymers,long acting injectables,low solubles,drug eluting stent coatings,plga,and hydrogel

Innocore pharmaceuticals operates in the Pharmaceutical manufacturing industry.

Innocore pharmaceuticals's revenue is 11m - 100m

Innocore pharmaceuticals has 11 - 50 employees.